RxDoctor Payments Data

Ingrid Scott, MD

Ophthalmology · Hershey, PANPI 1295799039

Payments from drug & device makers

$29,886in general payments, 2019–2025

Across 20 payments — averaging $1494.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron$11K
  • AbbVie$8K
  • Thrombogenics, Inc.$8K
  • Kowa Research Institute, Inc.$4K
$174,148in research payments, 2019–2025

Across 7 payments — averaging $24,878 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis Pharma AG$174K

What the payments were for

  • Consulting fees$28,75996%
  • Travel & lodging$8373%
  • Food & beverage$2911%

General payments by program year

19
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Regeneron3$10,509
AbbVie13$7,877
Thrombogenics, Inc.3$7,500
Kowa Research Institute, Inc.1$4,000

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$29,886 in reported general payments places this provider in the 90th percentile of 920 ophthalmology providers in Pennsylvania.

See all ophthalmology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$89,309
Medicare patients
348
Services billed
1,533

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate14$1,099
Ketorolac Tromethamine17$454

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Hershey

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →